The Cooper Companies, Inc. (COO) - Yahoo Finance

Find the latest The Cooper Companies, Inc. (COO) stock quote, history, news and other vital information to help you with your stock trading and investing.

$104
OFF

The Cooper Companies (COO) - Zacks Investment Research

4 weeks from now

The forecasts for The Cooper Companies, Inc. (COO) range from a low of $104 to a high of $130. The average price target represents a increase of $12.44 from the last closing price of $104.46.

zacks.com

$117.00
OFF

Cooper Companies (COO) Stock Forecast And Price Target 2024

4 weeks from now

Dec 22, 2024 · According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Cooper Companies is $117.00, with a high …

marketbeat.com

$1.04
OFF

Cooper Companies (COO) Stock Price, News & Analysis - MarketBeat

4 weeks from now

6 days ago · The Cooper Companies, Inc. (NASDAQ:COO) posted its quarterly earnings data on Thursday, December, 5th. The medical device company reported $1.04 earnings per share for …

marketbeat.com

$20
OFF

Cooper Companies (NasdaqGS:COO) Stock Forecast & Analyst …

4 weeks from now

Dec 3, 2024 · The Cooper Companies, Inc. NasdaqGS:COO Stock Report. Market Cap: US$20.9b. Add to watchlist. ... Other Information; View Valuation. Cooper Companies Future …

simplywall.st

$92.61
OFF

Zacks Research Issues Optimistic Outlook For COO Earnings

4 weeks from now

4 days ago · View Our Latest Analysis on Cooper Companies. Cooper Companies Trading Down 0.2 %. Shares of COO opened at $92.61 on Friday. Cooper Companies has a fifty-two week …

etfdailynews.com

90%
OFF

COO - The Cooper Companies, Inc. Stock Price Forecast 2024, …

4 weeks from now

The The Cooper Companies, Inc. (COO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $61.52, representing a -37.90% decrease …

stockscan.io

FAQs about The Cooper Companies, Inc. (COO) - Yahoo Finance Coupon?

What was Cooper companies' stock price in 2024?

Cooper Companies' stock was trading at $94.61 on January 1st, 2024. Since then, COO stock has increased by 11.9% and is now trading at $105.85. How were Cooper Companies' earnings last quarter? The Cooper Companies, Inc. (NASDAQ:COO) announced its quarterly earnings data on Wednesday, August, 28th. ...

Is Cooper companies (COO) a good stock to buy?

The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning. Cooper Companies ( NASDAQ:COO ) Second Quarter 2024 Results Key Financial Results Revenue: US$942.6m (up 7.4% from 2Q... ...

Where can I buy shares of Cooper Companies?

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cooper Companies own? ...

How did Cooper companies (COO) perform in the quarter?

The Cooper Companies, Inc. (NASDAQ:COO) announced its quarterly earnings data on Wednesday, August, 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.05. Cooper Companies's revenue for the quarter was up 7.8% on a year-over-year basis. ...

Are Cooper Companies insiders buying or selling more stock?

In the past three months, Cooper Companies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $27,637,427.00 in company stock. Only 2.00% of the stock of Cooper Companies is held by insiders. Only 24.39% of the stock of Cooper Companies is held by institutions. ...

Which institutional investors have changed their holdings of Cooper Companies?

A number of institutional investors have recently modified their holdings of the stock. JPMorgan Chase & Co. grew its stake in Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after purchasing an additional 573,908 shares in the last quarter. ...